DGFT Committee Minutes
Office of Directorate General of Foreign Trade New Delhi ‐0 ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐
Para 4.7 Decision
MEETING NUMBER : 38/82‐ALC4/2010 MEETING DATE : 21.12.2010 The Meeĕng No.38/82 in the year 2010‐11 to consider the cases under Duty Exempĕon Scheme (Chapter‐4) of Foreign Trade Policy, 2009‐14 pertaining to products falling in Chapter 29 and 30 was held on 21.12.2010 under the Chairmanship of Addl DGFT, Shri V.K. Gupta in his chamber. Following members were present:‐ 1. Shri Shaish Kumar, IA, DIPP 2. Shri D.N. Mathur, Dy.I.A, Department of Pharmaceuĕcals 3. Shri Krishan Kumar, Dy. DGFT 4. Shri Shyam Lal, FTDO At the outset, minutes of Norms Commiĥee Meeĕng No. 36/82 dated 07.12.2010 and 37/82 dated 14.12.2010 were raĕfied by the Commiĥee.
Case No. B‐326
M/s Scitech Specialiĕes Pvt. Ltd. Norms Commiĥee Meeĕng No. 38/11 F.No.01/82/050/00956/AM09/DES‐III Meeĕng Date 21.12.2010 RLA F. No. 03/95/040/00324/AM09 Adv. Lic. No.0310484762 dated 01.09.2008 Commiĥee considered case as per agenda and observed that the firm has obtained advance authorizaĕon for export of Cevamune Tablets Chlorine Nutralizer and now request of the firm for deleĕon of Chlorine Nutralizer is not jusĕfied. It was, therefore, decided to reject the request of the firm.
Case No. B‐327
M/s Shilpa Medicare Ltd. Norms Commiĥee Meeĕng No. 38/11 F.No.01/83/050/00095/AM07/DES‐III Meeĕng Date 21.12.2010 RLA F. No. 07/24/040/00046/AM07 Adv. Lic. No.0710044550 dated 26.04.2006 Commiĥee decided to call from the firm producĕon and consumpĕon data cerĕfied by Central Excise Authority. Accordingly, case was deferred for 15.02.2011.
Case No. B‐328
M/s Yasho Industries Pvt. Ltd. Norms Commiĥee Meeĕng No. 38/11 F.No.01/83/050/01040/AM08/DES‐III F.No.01/83/050/01730/AM08/DES‐III F.No.01/83/050/00335/AM07/DES‐III Meeĕng Date 21.12.2010 RLA F. No. 03/95/040/00476/AM08 RLA F. No. 03/95/040/00903/AM08 RLA F. No. 03/95/040/00371/AM07
Adv. Lic. No.0310439729 dated 16.08.2007 Adv. Lic. No.0310453620 dated 11.12.2007 Adv. Lic. No.0310386989 dated 27.06.2006 Commiĥee considered case as per agenda and in consultaĕon with technical authority present in meeĕng, decided to amend the descripĕon of export product to read as “Dipentamethylene Thiuram Tetrasulfide (Qureacc DPTT)” without any other change in the earlier decision of NC. RA concerned may take further necessary acĕon as per above decision of NC.
Case No. B‐329
M/s Star Orchem Internaĕonal Pvt. Ltd. Norms Commiĥee Meeĕng No. 38/11 F.No.01/82/050/01052/AM10/DES‐III F.No.01/82/050/00651/AM10/DES‐III Meeĕng Date 21.12.2010 RLA F. No. 50/24/040/00004/AM10 RLA F. No. 50/24/040/00006/AM10 Adv. Lic. No.5010000149 dated 25.09.2009 Adv. Lic. No.5010000150 dated 25.09.2009 Commiĥee decided to defer case for 04.01.2011 for comments of Department of C&PC.
Case No. B‐330
M/s Vivimed Labs Ltd Norms Commiĥee Meeĕng No. 38/11 F.No.01/85/050/00236/AM10/DES‐III Meeĕng Date 21.12.2010 RLA F. No. 09/24/040/00504/AM10 Adv. Lic. No.0910041262 dated 11.03.2010 Commiĥee decided to defer case for 18.01.2011 for comments of Department of C&PC.
Case No. B‐331
M/s Aurobindo Pharma Ltd. Norms Commiĥee Meeĕng No. 38/11 F.No.01/82/050/00585/AM10/DES‐III Meeĕng Date 21.12.2010 RLA F. No. 09/24/040/00006/AM10 Adv. Lic. No.0910038659 dated 23.07.2009 Commiĥee considered case as per agenda and in light of wriĥen comments forwarded by Department of Pharmaceuĕcals vide their O.M. No.35011/88/2010‐PI Norms dated 05.10.2010 and in consultaĕon with technical authority present in meeĕng, decided to allow import of Methylene Chloride to the extent of 14.12 kg/kg of export product without any other change in the decision taken in 27/82 meeĕng held on 05.10.2010.
Case No. B‐332
M/s Pab Organic Pvt. Ltd. Norms Commiĥee Meeĕng No. 38/11 F.No.01/82/050/01042/AM10/DES‐III
F.No.01/82/050/01119/AM10/DES‐III Meeĕng Date 21.12.2010 RA F.No. 34/24/040/00154/AM10 RA F.No. 34/24/040/00153/AM10 Adv. Lic. No.3410025955 dt. 22.12.09 Adv. Lic. No.3410025954 dt. 22.12.09 Commiĥee considered case as per agenda and decided to call for the firm for personal hearing on any Tuesday a├er confirmaĕon with the P.S. of the Chairman, NC‐3 at Phone No.23063419 or from Shri Krishan Kumar, Dy. DGFT & Conveynor NC‐3 at Tel. No.23061562, Ext. 380 or from Shyam Lal, FTDO at Tel.No.23061562 Ext. 269. Accordingly, the case was deferred for confirmaĕon of the firm. 1
Case No.:17/2/82‐ALC4/2010
Party Name:DORF‐KETAL CHEMICALS INDIA PVT.LTD. Meet No/Date:38/82‐ALC4/2010 21.12.2010 Status:Case Approved HQ File :01/82/050/01251/AM10/ RLA File :03/94/040/01001/AM10/ Lic.No/Date:0310560279 15.02.2010 Decision : Commiĥee considered case as per agenda and in light of wriĥen comments forwarded by Department of C&PC vide their U.O. No.14010/50/2006‐Ch.II dated 16.12.2010 and in consultaĕon with technical authoriĕes present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export product Exp. Qty. Sl.No. Import items Qty. allowed Organic Mixture Trade Name – SR 8114 containing 10% of (2‐Hydroxy Ethyl)2‐(Hepta Decenyl) Imadazoline) (10% of Amino Ethyl Ethanol Amine, 80% of Glyoxylic Acid 50%, 10% of Acumer 3100) 1 Kg. 1. Amino Ethyl Ethanol Amine 0.0675 kg 2. Glyoxylic Acid 50% 0.800 kg 3. Acumer3100 (Nonionic Funcĕonal Terpolymer) 0.10 kg 2
Case No.:5/52/82‐ALC4/2009
Party Name:VIVIMED LABS LIMITED 21.12.2010 Status:Case Deferred HQ File :01/82/050/01198/AM10/ RLA File :09/24/040/00496/AM10/ Lic.No/Date:0910041237 09.03.2010 Defer Date:18.01.2011 Decision :Commiĥee decided to defer case for 18.01.2011 for comments of Department of C&PC. 3
Case No.:14/52/82‐ALC4/2009
Party Name:RANBAXY LABORATORIES LTD 21.12.2010 Status:Case Approved HQ File :01/82/050/01207/AM10/ RLA File :05/24/040/00507/AM10/ Lic.No/Date:0510260189
10.03.2010 Decision : Commiĥee considered case as per agenda and in light of wriĥen comments forwarded by Department of Pharmaceuĕcals vide their O.M. No.35011/140/2010‐PI‐(Norms) dated 25.11.2010 and in consultaĕon with technical authority present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export product Exp. Qty. Sl.No. Import items Qty. allowed Cefprozil 1 Kg. 1. 7‐Amino‐3‐[(Z)‐propen‐1‐yl]‐3‐cepham‐4 carboxylic acid (7 APCA) 0.708 kg 2. Methylene Chloride 2.348 kg 3. Hexamethyl Disilizane 0.392 kg 4. Trimethyl Chloro Silane (TMCS) 0.273 kg 5. Imidazole 0.008 kg 6. D(‐)Para Hydroxy Phenyl Glycine Methyl Potassium Danesalt 1.05 kg 7. N‐Methyl Morpholine 0.007 kg 8. Ethyl Chloro Formate 0.406 kg 9. Dimethyl Formamide 3.324 kg 10. Acĕvated Carbon 0.078 kg 11. Acetone 2.268 kg 12. Methane Sulfonic Acid 0.016 kg 4
Case No.:29/52/82‐ALC4/2009
Party Name:AARTI INDUSTRIES LIMITED 21.12.2010 Status:Case Approved HQ File :01/82/050/01222/AM10/ RLA File :03/94/040/01071/AM10/ Lic.No/Date:0310564649 12.03.2010 Defer Date: Decision : Commiĥee considered case as per agenda and light of technical details furnished by the firm and in consultaĕon with technical authority present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export product Exp. Qty. Sl.No. Import items Qty. allowed Budesonide 1 Kg. 1. 1,4,9,(11)16‐Pregnatetraene‐3,20,Dione‐21 Acetate(3TR) 2.756 kg 5
Case No.:12/14/82‐ALC4/2010
Party Name:VDH INTERNATIONAL 21.12.2010 Status:Case Deferred HQ File :01/82/050/00374/AM11/ RLA File :05/24/040/00514/AM10/ Lic.No/Date:0510261659 Defer
01.04.2010 Date:18.01.2011 Decision : Commiĥee decided to defer case for 18.01.2011 for comments of Department of C&PC. 6
Case No.:2/3/82‐ALC4/2010
Party Name:VIVIMED LABS LIMITED 21.12.2010 Status:Case Deferred HQ File :01/82/050/00013/AM11/ RLA File :09/24/040/00549/AM10/ Lic.No/Date:0910041571 07.04.2010 Defer Date:18.01.2011 Decision : Commiĥee decided to defer case for 18.01.2011 for comments of Department of C&PC. 7
Case No.:29/18/82‐ALC4/2010
Party Name:CLEAN SCIENCE AND TECHNOLOGY PVT.LTD. 21.12.2010 Status:Case Approved HQ File :01/82/050/00572/AM11/ RLA File :31/24/040/00001/AM11/ Lic.No/Date:3110042802 08.04.2010 Decision : Commiĥee considered case as per agenda and in light of wriĥen comments forwarded by Department of C&PC vide their U.O. No.14010/6/2009‐Ch.II dated 16.12.2010 and in consultaĕon with technical authoriĕes present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export product Exp. Qty. Sl.No. Import items Qty. allowed Monomethyl Ether of Hydroquinone (99% purity) 1 Kg. 1. Anisole 1.17 kg 2. Hydrogen Peroxide (50%) 0.90 kg 3. Acetone 0.30 kg 8
Case No.:5/3/82‐ALC4/2010
Party Name:CAMPHOR & ALLIED PRODUCTS LIMITED, 21.12.2010 Status:Case Approved HQ File :01/82/050/00016/AM11/ RLA File :03/94/040/01138/AM10/ Lic.No/Date:0310568958 09.04.2010 Decision :Withdrawn as the case has already been approved by NC in 12/82 meeĕng held on 22.06.2010. 9
Case No.:36/6/82‐ALC4/2010
Party Name:VIVIMED LABS LIMITED 21.12.2010 Status:Case Deferred HQ File :01/82/050/00183/AM11/ RLA File :09/24/040/00033/AM11/ Lic.No/Date:0910041861 03.05.2010 Defer Date:18.01.2011 Decision : Commiĥee decided to defer case for 18.01.2011 for comments of Department of C&PC. 10
Case No.:60/14/82‐ALC4/2010
Party Name:CAMPHOR & ALLIED PRODUCTS Status:Case
LIMITED, 21.12.2010 Approved HQ File :01/82/050/00422/AM11/ RLA File :03/94/040/00108/AM11/ Lic.No/Date:0310573861 12.05.2010 Decision : Commiĥee considered case as per agenda and in light of wriĥen comments forwarded by Department of C&PC vide their U.O.No.14010/9/2005‐Ch.II dated 26.11.2010 and in consultaĕon with technical authority present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export Product Export Qty. Sl.No. Import items Qty. allowed Astrolide in Dipropylene Glycol Main Total Astrolide content 62.5% minimum 1 kg 1. Isoamylene 0.380 kg 2. Propylene Oxide 0.280 kg 3. Paraformaldehyde 0.088 kg 4. Dipropylene Glycol 0.350 kg 11
Case No.:57/22/82‐ALC4/2010
Party Name:CAMPHOR & ALLIED PRODUCTS LIMITED, 21.12.2010 Status:Case Approved HQ File :01/82/050/00710/AM11/ RLA File :03/94/040/00118/AM11/ Lic.No/Date:0310574865 18.05.2010 Decision : Commiĥee considered case as per agenda and in light of wriĥen comments forwarded by Department of C&PC vide their U.O.No.14010/9/2005‐Ch.II dated 26.11.2010 and in consultaĕon with technical authority present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export Product Export Qty. Sl.No. Import items Qty. allowed Astrolide in Isopropyl Myristate Main Total Astrolide content 62.5% minimum 1 kg 1. Isoamylene 0.380 kg 2. Propylene Oxide 0.280 kg 3. Isopropyl Myristrate 0.350 kg 12
Case No.:135/9/82‐ALC4/2010
Party Name:SAINOR LABORATORIES PVT LTD 21.12.2010 Status:Case Deferred HQ File :01/82/050/00350/AM11/ RLA File :09/24/040/00040/AM11/ Lic.No/Date:0910042075 19.05.2010 Defer Date:18.01.2011 Decision : Commiĥee decided to defer case for 18.01.2011 for comments of Department of C&PC. 13
Case No.:59/14/82‐ALC4/2010
Party Name:CIPLA LIMITED Status:Case
21.12.2010 Approved HQ File :01/82/050/00421/AM11/ RLA File :03/94/040/00186/AM11/ Lic.No/Date:0310575233 20.05.2010 Decision : Commiĥee considered case as per agenda and observed that the NOC for import of “HFA‐227 Propellant (1,1,1,2,3,3,3‐Heptafluoropropane gas)” has been received from Ministry of Environment & Forests vide their O.M. No.11/12/2010‐OC dated 26.11.2010. Commiĥee a├er detailed deliberaĕons and in light of wriĥen comments forwarded by Department of Pharmaceuĕcals vide their U.O. No.35011/265/2008‐PI‐III dated 17.03.2009 and in consultaĕon with technical authority present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export product Exp. Qty. Sl.No. Import items Qty. allowed Ipratropium Bromide 20 mcg inhaler (200MD) with 63 mcl Aerosol Valves 1 No. 1. Ipratropium Bromide 4.00 mg 2. 63 mcl Aerosol valve As per packing policy 3. 19 ml Aluminium Can 4. Acĕvators with dust covers/caps fiħng to 19ml Aluminium can 5. HFA‐227 Propellant (1,1,1,2,3,3,3‐ Heptafluoropropane gas) 21.12 mg Salbutamol 100 mcg and Ipratropium Bromide 20 mcg inhaler (200MD) with 63 mcl Aerosol valves 1 No. 1. Sulbutamol 20.00 mg 2. Ipratropium Bromide 4.00 mg 3. 19 ml Aluminium Can As per packing policy 4. 63 mcl Aerosol valve 5. Acĕvators with dust covers/caps fiħng to 19ml Aluminium can 6. HFA‐227 Propellant (1,1,1,2,3,3,3‐ Heptafluoropropane gas) 21.12 mg Budesonide 100 mcg inhaler (200MD) with 63 mcl Aerosol valves 1 No. 1. Budesonide 20.00 mg 2. 63 mcl Aerosol valve As per packing policy 3. 19 ml Aluminium Can 4. Acĕvators with dust covers/caps fiħng to 19ml Aluminium can 5. HFA‐227 Propellant (1,1,1,2,3,3,3‐ Heptafluoropropane gas) 21.12 mg Budesonide 200 mcg inhaler (200MD) with 63 mcl Aerosol valves 1 No. 1. Budesonide 40.00 mg 2. 63 mcl Aerosol valve As per packing policy 3. 19 ml Aluminium Can 4. Acĕvators with dust covers/caps fiħng to 19ml Aluminium can
HFA‐227 Propellant (1,1,1,2,3,3,3‐ Heptafluoropropane gas) 21.12 mg RA concerned may take further necessary acĕon as per above decision of NC subject to the condiĕon that firm shall maintain proper record for actual consumpĕon of Gas against this licence and pay duty on any un‐uĕlized gas since they have shown 20% overfilling of HFA‐227 Propellant Gas 14
Case No.:10/22/82‐ALC4/2010
Party Name:FDC LTD 21.12.2010 Status:Case Approved HQ File :01/82/050/00663/AM11/ RLA File :03/94/040/00954/AM10/ Lic.No/Date:0310576214 26.05.2010 Decision :Commiĥee considered case as per agenda and in light of wriĥen comments forwarded by Department of Pharmaceuĕcals vide their O.M. No.35011/145/2010‐PI Norms dated 25.11.2010 and in consultaĕon with technical authority present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export product Exp. Qty. Sl.No. Import items Qty. allowed Paracetamol, Phemirnamine Maleate, Phenylephrine & Ascorbic Acid Powder (Milistan Hot Tea) 6 gm Sachet 1. Paracetamol 505.0 mg/6 gm Sachet 2. Phemirnamine Maleate 25.25 mg/6 gm Sachet 3. Phenylephrine Hcl 10.1 mg/6 gm Sachet 4. Ascorbic Acid 202.0 mg/6 gm Sachet Note: The firm has not furnished approved composiĕon of export product Milistan HotTea Anĕcough and therefore, norms could not be fixed. 15
Case No.:20/22/82‐ALC4/2010
Party Name:ARCH PHARMALABS LTD 21.12.2010 Status:Case Approved HQ File :01/82/050/00673/AM11/ RLA File :03/94/040/00211/AM11/ Lic.No/Date:0310577127 03.06.2010 Decision : Commiĥee considered case as per agenda and in light of wriĥen comments forwarded by Department of Pharmaceuĕcals vide their O.M. No.35011/151/2010‐PI Norms dated 09.12.2010 and in consultaĕon with technical authority present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export product Exp. Qty. Sl.No. Import items Qty. allowed 1‐(4‐Azido‐5‐Trityloxymethyl‐ Tetrahydro‐Furan‐2‐YL)‐5‐Methyl‐ 1H‐Pyrimidine‐2,4‐Dione (Azido Compound) 1 kg 1. 4‐Methyl‐10‐Trityloxymethyl‐8,11‐ Dioxa‐2,6‐Diaza‐Tricyclo[7.2.1.02,7] Dodec‐6‐EN‐5‐one (Anhydro Compound) 1.067 kg
Dimethyl Sulfoxide 2.55 kg 3. Sodium Azide 0.15 kg 4. Methanol 1.067 kg 16
Case No.:34/22/82‐ALC4/2010
Party Name:WEXFORD LABORATORIES P LTD 21.12.2010 Status:Case Deferred HQ File :01/82/050/00687/AM11/ RLA File :07/24/040/00074/AM11/ Lic.No/Date:0710072310 17.06.2010 Defer Date:15.02.2011 Decision :Commiĥee decided to defer case for 18.02.2011 for comments of Department of Pharmaceuĕcals. 17
Case No.:36/22/82‐ALC4/2010
Party Name:EMCURE PHARMACEUTICALS LTD. 21.12.2010 Status:Case Approved HQ File :01/82/050/00689/AM11/ RLA File :31/24/040/00052/AM11/ Lic.No/Date:3110043681 21.06.2010 Decision : Commiĥee considered case as per agenda and in light of wriĥen comments forwarded by Department of Pharmaceuĕcals vide their O.M. No.35011/139/2010‐PI (Norms) dated 25.11.2010 and in consultaĕon with technical authority present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export product Exp. Qty. Sl.No. Import items Qty. allowed Mycophenolate Mofeĕl 1 Kg. 1. Mycophenolic Acid 0.941 kg 18
Case No.:108/22/82‐ALC4/2010
Party Name:MEDCHL CHEMICALS AND PHARMACEUTICALS PVT LTD 21.12.2010 Status:Case Deferred HQ File :01/82/050/00761/AM11/ RLA File :09/24/040/00028/AM11/ Lic.No/Date:0910042684 14.07.2010 Defer Date:15.02.2011 Decision :Commiĥee decided to defer case for 15.02.2011 for comments of Department of Pharmaceuĕcals. 19
Case No.:97/22/82‐ALC4/2010
Party Name:TONIRA PHARMA LTD, 21.12.2010 Status:Case Deferred HQ File :01/82/050/00750/AM11/ RLA File :34/24/040/00073/AM11/ Lic.No/Date:3410027520 16.07.2010 Defer Date:15.02.2011
Decision : Commiĥee decided to defer case for 15.02.2011 for comments of Department of Pharmaceuĕcals. 20
Case No.:31/26/82‐ALC4/2010
Party Name:LAFFANS PETROCHEMICALS LTD., 21.12.2010 Status:Case Deferred HQ File :01/82/050/00849/AM11/ RLA File :03/95/040/00085/AM11/ Lic.No/Date:0310583874 16.07.2010 Defer Date:18.01.2011 Decision :Commiĥee decided to forward a copy of applicaĕon to Petrochemicals Division of Department of C&PC for their comments. Accordingly, case was deferred for 18.01.2011. 21
Case No.:85/22/82‐ALC4/2010
Party Name:CIPLA LIMITED 21.12.2010 Status:Case Deferred HQ File :01/82/050/00738/AM11/ RLA File :03/94/040/00350/AM11/ Lic.No/Date:0310584093 19.07.2010 Defer Date:15.02.2011 Decision :Commiĥee decided to defer case for 15.02.2011 for comments of Department of Pharmaceuĕcals. 22
Case No.:34/18/82‐ALC4/2010
Party Name:MAHIMA LIFE SCIENCES PVT.LTD. 21.12.2010 Status:Case Deferred HQ File :01/82/050/00577/AM11/ RLA File :05/24/040/00147/AM11/ Lic.No/Date:0510268636 21.07.2010 Defer Date:18.01.2011 Decision :Commiĥee considered case as per agenda. The representaĕves of the firm appeared before the Commiĥee for personal hearing and explained the case. They informed the Commiĥee that the import item Dexamethasone Base IP/BP/USP (Crystalline) contains 40 Mesh. The Commiĥee pointed out that the firm had not indicated the same in their applicaĕon. Further, that they have also not included the parĕcle size of the export product in the applicaĕon. A├er detailed deliberaĕons and in consultaĕon with technical authoriĕes present in meeĕng, Commiĥee decided to call for Cerĕficate of Analysis in respect of export item and import item, copy of shipping bills and copy of Bills of Entry from the firm. Accordingly, case was deferred for 18.01.2011. 23
Case No.:35/18/82‐ALC4/2010
Party Name:MAHIMA LIFE SCIENCES PVT.LTD. 21.12.2010 Status:Case Deferred HQ File :01/82/050/00578/AM11/ RLA File :05/24/040/00151/AM11/ Lic.No/Date:0510268639 21.07.2010 Defer Date:18.01.2011 Decision : Commiĥee considered case as per agenda. The representaĕves of the firm appeared before the Commiĥee for personal hearing and explained the case. They informed the Commiĥee that the assays of the export product is not less than 90% and they will not be imporĕng second import item namely Triethyl Ortho Formate. A├er detailed deliberaĕons and in consultaĕon with technical authoriĕes present in meeĕng, Commiĥee decided to call for Cerĕficate of Analysis in respect of import item and Declaraĕon that the purity of export product shall not be less that 90% from the firm. Accordingly, case was deferred for 18.01.2011.
24
Case No.:36/18/82‐ALC4/2010
Party Name:MAHIMA LIFE SCIENCES PVT.LTD. 21.12.2010 Status:Case Approved HQ File :01/82/050/00579/AM11/ RLA File :05/24/040/00152/AM11/ Lic.No/Date:0510268642 21.07.2010 Decision : Commiĥee considered case as per agenda. The representaĕves of the firm appeared before the Commiĥee for personal hearing and explained the case. They informed the Commiĥee that the export product contain BP/USP. A├er detailed deliberaĕons and in consultaĕon with technical authoriĕes present in meeĕng, Commiĥee decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by the firm whichever is lower:‐ Export product Exp. Qty. Sl.No. Import items Qty. allowed Dexamethasone Sodium Phosphate BP/USP 1 Kg. 1. Dexamethasone Base 0.8 kg 25
Case No.:29/26/82‐ALC4/2010
Party Name:SARACA LABORATORIES LTD 21.12.2010 Status:Case Deferred HQ File :01/82/050/00847/AM11/ RLA File :09/24/040/00163/AM11/ Lic.No/Date:0910042998 06.08.2010 Defer Date:15.02.2011 Decision :Commiĥee decided to defer case for 15.02.2011 for comments of Department of Pharmaceuĕcals. 26
Case No.:34/26/82‐ALC4/2010
Party Name:DALAS BIOTECH LTD. 21.12.2010 Status:Case Deferred HQ File :01/82/050/00852/AM11/ RLA File :05/23/040/00122/AM11/ Lic.No/Date:0510270364 11.08.2010 Defer Date:15.02.2011 27
Case No.:4/22/82‐ALC4/2010
Party Name:MEHTA (API) PVT.LTD 21.12.2010 Status:Case Deferred HQ File :01/82/050/00657/AM11/ RLA File :03/95/040/00358/AM11/ Lic.No/Date:0310587875 16.08.2010 Defer Date:15.02.2011 28
Case No.:23/26/82‐ALC4/2010
Party Name:PUNJAB CHEMICALS AND CROP PROTECTION LTD., 21.12.2010 Status:Case Deferred HQ File :01/82/050/00841/AM11/ RLA File :03/95/040/00350/AM11/ Lic.No/Date:0310588666 Defer
20.08.2010 Date:18.01.2011 Decision : Commiĥee decided to defer case for 18.01.2011 for comments of Department of C&PC. 29
Case No.:35/26/82‐ALC4/2010
Party Name:DHANUKA LABORATORIES LTD. 21.12.2010 Status:Case Deferred HQ File :01/82/050/00853/AM11/ RLA File :05/23/040/00085/AM11/ Lic.No/Date:0510271131 20.08.2010 Defer Date:15.02.2011 30
Case No.:26/26/82‐ALC4/2010
Party Name:NECTAR LIFESCIENCES LIMITED, 21.12.2010 Status:Case Deferred HQ File :01/82/050/00844/AM11/ RLA File :22/24/040/00035/AM11/ Lic.No/Date:2210010327 24.08.2010 Defer Date:15.02.2010 31
Case No.:2/26/82‐ALC4/2010
Party Name:AUROBINDO PHARMA LIMITED 21.12.2010 Status:Case Deferred HQ File :01/82/050/00820/AM11/ RLA File :09/24/040/00226/AM11/ Lic.No/Date:0910043503 14.09.2010 Defer Date:15.02.2011 32
Case No.:3/26/82‐ALC4/2010
Party Name:MAHIMA LIFE SCIENCES PVT.LTD. 21.12.2010 Status:Case Deferred HQ File :01/82/050/00821/AM11/ RLA File :05/24/040/00222/AM11/ Lic.No/Date:0510272765 14.09.2010 Defer Date:18.01.2011 Decision : Commiĥee considered case as per agenda. The representaĕves of the firm appeared before the Commiĥee for personal hearing and explained the case. They informed the Commiĥee that the import item Dexamethasone Base IP/BP/USP (Crystalline) contains 40 Mesh. The Commiĥee pointed out that the firm had not indicated the same in their applicaĕon. Further, that they have also not included the parĕcle size of the export product in the applicaĕon. A├er detailed deliberaĕons and in consultaĕon with technical authoriĕes present in meeĕng, Commiĥee decided to call for Cerĕficate of Analysis in respect of export item and import item, copy of shipping bills and copy of Bills of Entry from the firm. Accordingly, case was deferred for 18.01.2011. 33
Case No.:49/26/82‐ALC4/2010
Party Name:SUVEN LIFE SCIENCES LIMITED 21.12.2010 Status:Case Deferred HQ File :01/82/050/00867/AM11/ RLA File :09/24/040/00245/AM11/ Lic.No/Date:0910043540 17.09.2010 Defer Date:15.02.2011
34
Case No.:4/30/82‐ALC4/2010
Party Name:PRACHI PHARMACEUTICALS PVT LTD 21.12.2010 Status:Case Deferred HQ File :01/82/050/00923/AM11/ RLA File :03/95/040/00095/AM11/ Lic.No/Date:0310595471 06.10.2010 Defer Date:18.01.2011 Decision : Commiĥee decided to defer case for 18.01.2011 for comments of Department of C&PC. 35
Case No.:6/30/82‐ALC4/2010
Party Name:ALCON BIOSCIENCES PRIVATE LIMITED Meet No/Date:38/82‐ALC4/2010 21.12.2010 Status:Case Deferred HQ File :01/82/050/00925/AM11/ RLA File :03/94/040/00472/AM11/ Lic.No/Date:0310595543 06.10.2010 Defer Date:15.02.2011 36
Case No.:2/30/82‐ALC4/2010
Party Name:JUBILANT LIFE SCIENCES LIMITED (FORMERLY JUBILANT 21.12.2010 Status:Case Deferred HQ File :01/82/050/00921/AM11/ RLA File :05/23/040/00168/AM11/ Lic.No/Date:0510274506 08.10.2010 Defer Date:18.01.2011 Decision : Commiĥee decided to defer case for 18.01.2011 for comments of Department of C&PC. 37
Case No.:3/30/82‐ALC4/2010
Party Name:RANBAXY LABORATORIES LTD 21.12.2010 Status:Case Approved HQ File :01/82/050/00922/AM11/ RLA File :05/24/040/00233/AM11/ Lic.No/Date:0510274511 08.10.2010 Decision : Commiĥee considered case as per agenda and in light of wriĥen comments forwarded by Department of Pharmaceuĕcals vide their O.M. No.35011/140/2010‐PI‐(Norms) dated 25.11.2010 and in consultaĕon with technical authority present in meeĕng, decided to raĕfy norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:‐ Export product Exp. Qty. Sl.No. Import items Qty. allowed Esomeprazole Magnesium Trihydrate 1 Kg. 1. (D‐Det) D‐Diethyl Tartrate 0.164 kg 2. 5‐Methoxy‐2‐Mercaptobenzimidazole (Metmercazole) 0.702 kg 3. Cumene Hydroperoxide 0.669 kg 4. Diisopropyl Ethylamine 0.098 kg 5. Magnesium Sulfate Dried 0.284 kg 6. Methanol 6.00 kg 7. Potassium Methoxide (32% Sol) 0.989 kg
Pyramethyl Alcohol 0.633 kg 9. Thionyl Chloride 0.585 kg 10. Titanium‐Isopropoxide 0.109 kg 11. Toluene 8.40 kg 38
Case No.:3/34/82‐ALC4/2010
Party Name:GALPHA LABORATORIES LIMITED, 21.12.2010 Status:Case Deferred HQ File :01/82/050/01009/AM11/ RLA File :03/94/040/00638/AM11/ Lic.No/Date:0310600646 09.11.2010 Defer Date:15.02.2011 Outside Agenda The Commiĥee looked into the papers available in Policy‐VI Secĕon’s file No.01/92/180/120/AM‐11/PC‐VI. This file relates to PE‐1(A)/2007‐GNR to PE‐4(A)/2007‐ GNR dated 31.01.2007 registered by CBI, Gandhinagar. The Commiĥee considered the case with the limited purpose to give its opinion as to whether these licences were correctly issued under SION A‐1945 and whether use of word ‘compacted granules’ instead of ‘granules’ resulted in undue advantage to the firm. The Commiĥee noted following facts:‐ 1. SION A‐1945 is as under:‐ “ SION No. Export Item Qty. Import item Qty. allowed A‐1945 Drug Formulaĕon‐ Dispersible/Soluble Powder & Granules 1 kg. Relevant bulk drug 1.01 kg/kg content in the export product Note:‐ The content of bulk drug shall be worked out as per Drug Manufacturing Licence for the formulaĕon in the dosage form.” 2. Drug Manufacturing Licence issued by Food & Drug Administraĕon shows the name of the product as under:‐ 1. Paracetamol compacted granules 99.0% w/w. 2. Analgin compacted granules 99.0% w/w. 3. Trimethoprin compacted granules 99.0% w/w.
4. Norfloxacin compacted granules 99.0% w/w. 5. Diclofenac Sodium compacted granules 99.0% w/w. The Commiĥee observed that compacĕng process is a manufacturing process in itself which is intermediate stage before making tablet. As per SION A‐412, a wastage of 2% is allowed for making tablets from relevant bulk drug. SION A‐1945 prescribes 1% wastage for the product ‘Drug Formulaĕon‐Dispersible/Soluble Powder & Granules’ from relevant bulk drug as per their Drug Manufacturing Licence. Thus, by adding the word compacted before the granules in the advance licence, no extra wastage has become available to the firm. Addiĕon of word compacted before granules was as per DML, issued by Food & Drug Administraĕon, Gujrat. Therefore, the Commiĥee opines that addiĕon of word ‘compacted’ before granules has not resulted in any undue benefit to the firm & as a maĥer of fact while compacĕng granules, a liĥle extra wastage is involved. XXXXXXXXXXXXXXXXX
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis has been generated for this document yet.